July 2025

The most anticipated trials at ESC 2025 ()
Tirzepatide demonstrates cardiovascular protection in head-to-head trial with dulaglutide ()
Pilot study looks at same-day discharge PCI for acute coronary syndromes ()
Colchicine reduces risk of some TAVR complications ()
Boston Scientific warns that certain defibrillation leads may put patients at risk ()
FDA clears wearable heart device that captures multiple signals at once ()
Smoking cannabis may not impact heart health of older CAD patients ()
Successful outreach program brings heart screenings to underserved communities ()
Artificial heart developer gains key approval as money troubles continue ()
FDA announces Class I recall due to heart pump controller issue ()
The best heart hospitals in the United States ()
ICD patients may experience fear, anxiety or depression due to their devices ()
CCTA could make invasive angiography a thing of the past ()
FDA clears first robotically guided EP mapping catheter for ablation ()
New drug candidate for AFib fails in first-in-human trial—in fact, it made matters worse ()
Edwards Lifesciences loses TAVR leader to robotics firm, announces replacement ()
How drinking habits influence heart health ()
How to choose between CABG and PCI when treating coronary artery disease ()
Trump administration takes aim at ultra-processed foods, highlighting heart risks ()
New gene therapy for rare heart condition gains FDA’s fast track designation ()
Interest rising in CKM syndrome as connections become clearer ()
Complications after intravascular lithotripsy are rare, real-world data confirm ()
‘This trend is encouraging’: Radial access for PCI now preferred in US ()
Surgeons perform world’s first on-table heart reanimation to save infant’s life ()
Q&A: What Medicare covering TriClip means for heart patients with leaky tricuspid valves ()
Widespread use of polypills could prevent up to 72 million heart disease deaths ()
AI software takes cardiac risk assessments to another level ()
How pairing SAVR with additional heart surgeries affects mortality risk ()
Medtronic receives key approvals for automated insulin pump ()
Wearable tech company pushes back after warning from FDA ()
New device could make it easier than ever for cardiologists to perform BASILICA before TAVR ()
Stroke risk after TAVR still much higher for female patients ()
Heartflow, a leader in AI-powered imaging evaluations, files for IPO ()
New data highlight how Heartflow's AI software drives major shifts in heart care ()
First patient treated with BASILICA before valve-in-valve TAVR in a mechanically-expanded valve ()
AHA data challenge explores links between inflammation and heart disease ()
What is chronic venous insufficiency? Cardiologist shares perspective on President Trump’s diagnosis ()
Surgeons perform world’s first robotic-assisted implant of biventricular assist device ()
New Philips platform offers AI-powered ECG tools from outside vendors ()
The power of prevention: Cardiologist says proactive patient care can make a big difference later in life ()
New ASE president outlines key initiatives in cardiac ultrasound ()
Medtronic expands peripheral portfolio with new distribution deal ()
FDA clears AI-powered software for real-time TAVR guidance ()
ASNC lobbies Congress to curb prior authorization, oppose AUC mandates and embrace payment reform ()
CMS proposal includes cardiologist pay bump—cuts to high-value services still a concern ()
Yes, researchers argue, vitamin D supplements help protect the heart ()
Update to Johnson & Johnson PFA platform gains FDA approval ()
AI-enhanced echocardiography improves early detection of cardiac amyloidosis ()
FDA approves Bayer's finerenone to treat wide range of heart failure patients ()
FDA details multiple Class I recalls for Edwards Lifesciences surgical devices ()
CMS proposes Medicare coverage for renal denervation ()
AI-enabled coronary plaque evaluations included in new RBM guidelines ()
ASE shares new recommendations for evaluating LV diastolic function, HFpEF ()
Myval TAVR valve associated with positive durability data after 4 years ()
Medicare now covers TriClip procedures for patients with symptomatic tricuspid regurgitation ()
Cardiology still No. 2 in FDA-cleared clinical AI algorithms, trailing only radiology ()
World’s first patient receives new-look heart pump—cardiologist ‘impressed’ by device’s performance ()
Statin use may protect patients from subarachnoid hemorrhages ()
‘The start of a paradigm shift’: FDA clears first over-the-counter cuffless blood pressure monitor ()
Early occlusion after CABG much more likely for female patients ()
FDA grants breakthrough therapy designation to new drug candidate for FA cardiomyopathy ()
Medical malpractice lawsuits are rare in sports cardiology—but they can cost providers millions ()
With MPFS proposal on the way, electrophysiology groups outline their priorities ()
New TAVR valve from MiRus linked to positive early outcomes ()
EHR-driven PCI risk assessments could make a world of difference ()
FDA expands approval of Boston Scientific’s Farapulse PFA system ()
No biopsy required: Blood test could spot signs of rejection in heart transplant recipients ()
Radiation in the cath lab: Tracking state-level regulations for cardiologists ()
Beloved cardiologist killed in airstrike—he was one of Gaza’s last heart doctors ()
PFA market heats up as medtech companies announce new investments ()
FDA shares warning after Johnson & Johnson heart pump controllers linked to 3 deaths ()
Vaccines—for the flu, COVID-19 and other infections—are a ‘foundational pillar’ of heart protection ()
Medtronic’s new ECMO system receives a key approval ()
Cusp overlap technique improves TAVR outcomes, new meta-analysis confirms ()
New guidelines help interventional cardiologists manage chronic venous disease ()